Caroline Litchfield

Director, Organon & Co.

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

  • Apr 29, 2026Shares withheld for tax 1,938 shares at $110.03 of Merck & Co.5
  • Apr 29, 2026Exercised options 3,935 shares at $110.03 of Merck & Co.5
  • Feb 4, 2026Sold 41,997 shares at $119.61 of Merck & Co.6
  • Feb 4, 2026Exercised options 41,997 shares at $53.06 of Merck & Co.6
  • Jan 26, 2026Granted 15,852 shares at $107.40 of Merck & Co.7
  • Jan 27, 2025Granted 23,432 shares at $97.94 of Merck & Co.8
  • Feb 14, 2024Sold 38,291 shares at $125.50 of Merck & Co.9
  • Feb 14, 2024Exercised options 38,291 shares at $58.08 of Merck & Co.9
  • Jan 22, 2024Granted 19,208 shares at $119.43 of Merck & Co.10
  • May 1, 2023Shares withheld for tax 427 shares at $115.47 of Merck & Co.11
  • May 1, 2023Exercised options 866 shares at $115.47 of Merck & Co.11
  • Jan 23, 2023Granted 2,656 shares at $109.88 of Merck & Co.12
  • May 3, 2022Shares withheld for tax 373 shares at $87.65 of Merck & Co.13
  • May 3, 2022Exercised options 773 shares at $87.65 of Merck & Co.13
  • May 1, 2022Shares withheld for tax 427 shares at $88.69 of Merck & Co.14
  • May 1, 2022Exercised options 866 shares at $88.69 of Merck & Co.14
  • Feb 24, 2022Granted 2,429 shares at $73.51 of Merck & Co.15
  • Nov 4, 2021Sold 18,335 shares at $91.00 of Merck & Co.16
  • Nov 4, 2021Exercised options 22,683 shares of Merck & Co.16